BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
3.314
+0.105 (3.26%)
At close: Jul 31, 2026
BioStem Technologies Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 59 | 64 | 230 | 95 | 36 | 10 | |
Market Cap Growth | -69.08% | -72.22% | 142.79% | 161.02% | 267.00% | -88.46% |
Enterprise Value | 48 | 40 | 220 | 101 | 40 | 11 |
Last Close Price | 3.31 | 3.81 | 13.84 | 5.86 | 2.99 | 1.04 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 7.43 | - | - | - |
Forward PE | - | 18.14 | 6.85 | 8.62 | 23.44 | - |
PS Ratio | 1.56 | 1.35 | 3.31 | 5.69 | 5.29 | 2.28 |
PB Ratio | 1.84 | 1.64 | 5.76 | -70.60 | -9.21 | -1.71 |
P/TBV Ratio | 6.92 | 1.65 | 5.83 | - | - | - |
P/FCF Ratio | 31.71 | 9.71 | 9.59 | - | 606.05 | - |
P/OCF Ratio | 11.65 | 6.44 | 9.42 | - | 119.78 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.28 | 0.85 | 3.16 | 6.04 | 5.87 | 2.53 |
EV/EBITDA Ratio | - | - | 7.03 | - | - | - |
EV/EBIT Ratio | - | - | 7.08 | - | - | - |
EV/FCF Ratio | 26.08 | 6.11 | 9.16 | - | 672.38 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.10 | 0.09 | 0.11 | -3.55 | -1.32 | -0.84 |
Debt / EBITDA Ratio | - | - | 0.14 | - | - | - |
Debt / FCF Ratio | 1.77 | 0.51 | 0.18 | - | 86.82 | - |
Net Debt / Equity Ratio | -0.33 | -0.67 | -0.46 | -3.37 | -1.12 | -0.79 |
Net Debt / EBITDA Ratio | 0.74 | 55.82 | -0.59 | -0.66 | -0.99 | -3.44 |
Net Debt / FCF Ratio | -5.63 | -3.98 | -0.77 | -1.26 | 73.95 | -29.89 |
Asset Turnover | 0.37 | 0.88 | 1.91 | 1.85 | 2.24 | - |
Inventory Turnover | 1.41 | 1.30 | 11.07 | 2.39 | 2.69 | - |
Quick Ratio | 0.86 | 3.66 | 2.56 | 0.74 | 0.13 | 0.10 |
Current Ratio | 1.14 | 4.12 | 2.89 | 0.81 | 0.24 | 0.14 |
Return on Equity (ROE) | -48.64% | -16.63% | 160.46% | - | - | - |
Return on Assets (ROA) | -9.06% | -0.80% | 53.38% | -48.94% | -95.34% | - |
Return on Capital Employed (ROCE) | -46.40% | -1.80% | 77.10% | 665.50% | 163.60% | 41.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -32.87% | -10.28% | 13.47% | -8.94% | -19.78% | -14.59% |
FCF Yield | 3.15% | 10.29% | 10.43% | -3.80% | 0.17% | -1.54% |
Buyback Yield / Dilution | 28.42% | 22.90% | -58.30% | -20.18% | 2.40% | -130.37% |